High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis. (Q41185159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

3 March 2020

main subject

0 references

author

Brian A. Fox

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Kristine Holgersen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Burak Kutlu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Kyle Serikawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

James Lord

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Axel Kornerup Hansen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Thomas Lindebo Holm

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

20 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

Journal of Crohn's and Colitis

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

492-506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795566%20AND%20SRC:MED&resulttype=core&format=json

Genomics and the multifactorial nature of human autoimmune disease

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Insights into IBD Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Reconstitution of Scid mice with CD4+CD25- T cells leads to rapid colitis: an improved model for pharmacologic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

The role of costimulatory molecules CD80 and CD86 and IFNgamma in the pathogenesis of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Increased expression of IL-16 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-γ-induced signaling in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Genome-wide expression profiling implicates a MAST3-regulated gene set in colonic mucosal inflammation of ulcerative colitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

The role of CDX2 in intestinal homeostasis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Gene expression changes in the colon epithelium are similar to those of intact colon during late inflammation in interleukin-10 gene deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Utility of faecal calprotectin analysis in adult inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

The chemical biology of nitric oxide: implications in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Chemokines in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

The monocyte-macrophage axis in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Mucosal macrophages in intestinal homeostasis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Gene expression variation between mouse inbred strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Piroxicam treatment augments bone abnormalities in interleukin-10 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Patterns of early gut colonization shape future immune responses of the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Rapid development of colitis in NSAID-treated IL-10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Piroxicam treatment of IL-10-deficient mice enhances colonic epithelial apoptosis and mucosal exposure to intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

Intestinal homeostasis and its breakdown in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050

CTLA4 -1661A/G and 3'UTR long repeat polymorphisms are associated with ulcerative colitis and influence CTLA4 mRNA and protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJV050